1034 related articles for article (PubMed ID: 17012043)
1. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy in children with newly-diagnosed medulloblastoma.
Grill J; Dufour C; Kalifa C
Lancet Oncol; 2006 Oct; 7(10):787-9. PubMed ID: 17012036
[No Abstract] [Full Text] [Related]
3. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
[TBL] [Abstract][Full Text] [Related]
7. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
Grill J; Sainte-Rose C; Jouvet A; Gentet JC; Lejars O; Frappaz D; Doz F; Rialland X; Pichon F; Bertozzi AI; Chastagner P; Couanet D; Habrand JL; Raquin MA; Le Deley MC; Kalifa C;
Lancet Oncol; 2005 Aug; 6(8):573-80. PubMed ID: 16054568
[TBL] [Abstract][Full Text] [Related]
8. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
10. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
[TBL] [Abstract][Full Text] [Related]
11. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol.
von Bueren AO; Friedrich C; von Hoff K; Kwiecien R; Müller K; Pietsch T; Warmuth-Metz M; Hau P; Benesch M; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2015 Nov; 51(16):2434-43. PubMed ID: 26254812
[TBL] [Abstract][Full Text] [Related]
12. High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.
Bergthold G; El Kababri M; Varlet P; Dhermain F; Sainte-Rose C; Raquin MA; Kieffer V; Goma G; Grill J; Valteau-Couanet D; Dufour C
Pediatr Blood Cancer; 2014 May; 61(5):907-12. PubMed ID: 24470384
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
14. Outcome and prognostic factors of radiation therapy for medulloblastoma.
Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
16. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
[TBL] [Abstract][Full Text] [Related]
18. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in adults: clinical characteristics and treatment.
Brandes AA; Palmisano V; Monfardini S
Cancer Treat Rev; 1999 Feb; 25(1):3-12. PubMed ID: 10212586
[TBL] [Abstract][Full Text] [Related]
20. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
